Redefining Medicine

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, hosts Jessica Carter and Dr. Lexi Gonzales explore advanced cellular rejuvenation strategies with Dr. Greg Kelly—a naturopathic physician, author of Shape Shift, and Chief Product Officer at Qualia who is a leading expert in nootropics and longevity science. Dr. Kelly outlines a "gardening" approach to cellular health, advocating for an intermittent "hit-and-run" dosing protocol where senolytics are used to "prune" inflammatory senescent cells (the "yellow leaves") before introducing stem cell support, rather than using daily dosing which can lead to adaptation or exhaustion. He utilizes the analogy of the "four doors" of cellular stress to explain why clearing the biological terrain of "zombie cells" is a necessary prerequisite for effective stem cell therapy, ultimately recommending a practical monthly cycle—such as two days of senolytics followed by four days of stem cell support—to reduce systemic inflammation and improve cognitive function.

For access to episode resources, click HERE.

On the next episode of Redefining Health, we'll be joined by Christopher Davis to dive into the fascinating topic of metabolic health—what it truly means and how practitioners can effectively discuss it with their patients.

Metabolic health is deeply tied to mitochondrial function, the "powerhouses" of our cells that drive energy production. When mitochondrial health is compromised, it can lead to a range of issues, from poor energy levels to chronic diseases. Factors such as oxidative stress, poor diet, lack of exercise, and environmental toxins all play a role in mitochondrial dysfunction.

In this episode, we'll explore:

• What metabolic health really means and why it's essential for overall well-being.

• How practitioners can simplify the concept for patients and emphasize the importance of lifestyle factors like diet, exercise, and stress management.

• The role of VO2 Max as a powerful yet underutilized tool for assessing cardiovascular and metabolic health.

VO2 Max, which measures the body's ability to utilize oxygen during exercise, is one of the best indicators of mitochondrial and cardiovascular health. Despite its value, it's not used enough in clinical practice. We'll discuss why this metric matters and how it can be integrated into patient care to provide a more comprehensive picture of health.

Join us for this insightful conversation as we redefine what it means to achieve and maintain metabolic health.

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest, host Tom Blue interviews Harry Bane, CEO of Lifespan.MD, about a novel investment model for concierge medicine dubbed "Entrepreneurial Equity". Unlike traditional private equity that often focuses on cost-cutting, Bane explains that Lifespan.MD builds long-term partnerships with established physician-entrepreneurs, allowing them to retain clinical autonomy while leveraging shared infrastructure, AI technology, and a collaborative "brain trust" to drive organic growth rates of 30–40%. The conversation highlights the Company's origin story—born from a patient-doctor relationship—and its five core values, emphasizing how the model reinvigorates practitioners by turning their practices into tangible wealth assets through equity while solving critical succession planning and supply-demand challenges in the longevity sector.

For access to episode resources, click HERE.

In this episode of the Innovations and Clinical Implementation podcast, hosts Andy Crosby and Dr. Chris D'Adamo explore the synergistic role of nitric oxide and hydrogen sulfide in male sexual longevity with Dr. Miles Spar—a leading authority and educator specializing in men's health and personalized performance medicine. The discussion centers on a recent 600-person randomized trial of Calroy Health Sciences' Vasconox HP, which demonstrated that hydrogen sulfide acts as a natural PDE5 inhibitor to extend the vasodilating effects of nitric oxide for up to 24 hours, significantly improving erectile function and orgasm ability compared to placebo. Dr. Spar highlights the clinical importance of addressing upstream endothelial health rather than relying solely on pharmaceuticals, noting that treating erectile dysfunction in patients with poor metabolic health without fixing nitric oxide production is akin to "filling a bathtub with the drain open".

For access to episode resources, click HERE.

On the next episode of the Redefining Medicine podcast, we are thrilled to welcome Dr. Mark Houston, a renowned leader in cardiometabolic health and preventive cardiology. Dr. Houston will delve into his groundbreaking work on reversing plaque buildup in the arteries, sharing insights from over a decade of research and development.

He will discuss his innovative protocol, which has demonstrated a remarkable 4-5% reduction in calcium scores—a key marker of heart health. As a pioneer in the field, Dr. Houston has dedicated his career to advancing strategies for improving cardiovascular outcomes and optimizing overall health.

Don't miss this enlightening conversation with one of the foremost experts in cardiometabolic health!

In this episode of the *Innovations and Clinical Implementation* podcast recorded at LongevityFest, hosts Tom Blue and Chris D'Adamo discuss the rapid evolution of epigenetic testing with Ryan Smith. Ryan Smith is the founder and global head of research and development at TruDiagnostic, a CLIA-certified lab and health data company that has built one of the world's largest private epigenetic databases to advance the measurement of biological aging. The discussion traces the 140% year-over-year growth in consumer interest regarding biological age and explores how TruDiagnostic utilizes AI to interpret over 1.3 million DNA methylation sites to validate longevity interventions in clinical trials. Smith previews the upcoming release of "methylation risk scores" that can predict the onset of diseases like COPD and Lyme disease, and details the development of "Epigenetic Biomarker Proxies" (EBPs) intended to eventually replace traditional labs by deriving thousands of metrics—such as HbA1c, CRP, and environmental toxins—from a single finger stick.

For access to episode resources, click HERE.

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, host Dr. Lexi Gonzales explores the intersection of AI and gut health with Dr. Helen Messier, a physician and molecular immunologist who serves as the Chief Medical and Science Officer at Fountain Life; Dr. Leo Grady, the founder of Jona and an AI expert who previously led the team achieving the first FDA approval for an AI product in pathology; and Dr. Lawrence Kosinski, a gastroenterologist and founder of Sonar MD who is a national leader in value-based care. The panel discusses how Jona's AI platform processes over 220,000 studies to identify dysbiotic patterns that antedate clinical disease—ranging from metabolic liver disease and colon polyps to Parkinson's and cardiovascular issues linked to TMAO—thereby moving clinical focus from "symptoms to systems". The experts emphasize the mechanism of the gut-brain axis, noting that metabolites like butyrate derived from soluble fiber are essential for stabilizing the blood-brain barrier and DNA, while warning that popular GLP-1 agonists, though effective for weight loss, can "collapse" microbiome diversity and require careful monitoring.

For access to episode resources, click HERE.

On the next episode of Redefining Medicine, we'll be joined by an incredible panel of experts, including Jim LaValle, Sahar Swidan, and Drs. Crozier and Schwartz. Together, they will discuss the launch of the groundbreaking new A4M Fellowship and pave the way for exciting developments in 2026.

This episode will provide:

1. Insights into the vision and goals of the new A4M Fellowship.

2. A look back at the program's achievements as it concludes in 2025.

3. A preview of what's on the horizon for 2026 and beyond.

Don't miss this opportunity to hear from thought leaders shaping the future of Longevity medicine and advancing the field in transformative ways.

In this episode of the Innovations and Clinical Implementation podcast, hosts Tom Blue and Sonia Horner discuss the future of AI-driven medicine with Dr. Don Brown, a physician entrepreneur and the former founder of LifeOmic who emerged from retirement to create Bioscope.ai. The conversation explores how Bioscope.ai functions as a revolutionary "AI Medical Colleague" by aggregating vast datasets—including whole genome sequencing, EMRs, and multi-omics—into a secure cloud repository that feeds an orchestration layer of multiple LLMs grounded in academic research. Dr. Brown details the platform's "synoptic view," an interface inspired by high-performance aircraft that visualizes 15 dimensions of health on a 3D wireframe, and introduces "Lumina," an AI persona that learns a physician's specific style to generate personalized care plans, ultimately allowing practices to offer high-value subscription models that turn static health data into a dynamic asset.

For access to episode resources. https://sites.google.com/ovationlab.com/innovationsinclinicalimplement/home

In this episode of the Innovations and Clinical Implementation podcast, hosts Dr. Lexi Gonzales and Tom Blue interview Dr. Sundeep Dugar, a pharmaceutical drug hunter with nearly 40 years of experience in small molecule discovery who serves as the co-founder and Chief Scientific Officer at Blue Oak Nutraceuticals. The conversation focuses on the development of Mitocatalyst, a precision-formulated epicatechin designed to mimic the mitochondrial biogenesis normally triggered by exercise. Dr. Dugar reveals his breakthrough discovery that exercise-induced Reactive Oxygen Species (ROS) signal the mitochondria to produce a specific steroid—11-beta hydroxyprogesterone—and explains how Mitocatalyst utilizes nanomolar doses of epicatechin to molecularly mimic this steroid, distinguishing it from high-dose antioxidant protocols that paradoxically blunt these beneficial signals. The discussion uses the metaphor of building a "fireplace" (mitochondria) to burn "firewood" (nutrition), positioning the supplement as a critical intervention for aging patients or those unable to exercise.

For access to episode resources: https://sites.google.com/ovationlab.com/innovationsinclinicalimplement/home